Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
• The stock remains down 49.45% over the past year.
4DMEDICAL Ltd is an Australian medical technology company that has developed XV Technology — a proprietary software platform that uses standard MRI or CT scanners to produce four-dimensional functional images of lung ventilation. Unlike conventional anatomical imaging that shows what lungs look like, XV …
AFT Pharmaceuticals Ltd is a New Zealand-headquartered specialty pharmaceutical company that develops, licenses and markets pharmaceutical products across Australia, New Zealand and internationally through licensing arrangements with global pharmaceutical companies. The company has a portfolio spanning both consumer health over-the-counter products and prescription medicines, …
Clarity Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company developing copper-based theranostics — compounds that use radioactive copper isotopes for both imaging (diagnostics) and therapy of cancer. The company's approach uses copper's unique properties, combined with targeting molecules, to selectively deliver radioactive copper to cancer …
• Island Pharmaceuticals shares rose 26.67% on 7 July 2026 after announcing government and regulatory approvals for Galidesivir use in Uganda.
• Botanix Pharmaceuticals shares rose 13.64% to AUD 0.025 during the morning session on 7 July 2026 after the company announced a favourable European patent update.
Entropy Neurodynamics Ltd (ASX:ENP) rose 6.25% in the latest session, with shares trading at $0.034 on 7 Jul 2026. The move draws investor attention to the latest developments at the company and what they may mean for the near and longer-term investment case. For …
Argent BioPharma Ltd (ASX:RGT) surged 168.57% in the latest session on significant news, with shares trading at $0.094 on 7 Jul 2026. The move draws investor attention to the latest developments at the company and what they may mean for the near and longer-term …
• Global demand for implantable hearing solutions remains supportive of long-term growth.
• Research and development remain central to the company's long-term strategy.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…